CF
FLGT icon

Corebridge Financial’s Fulgent Genetics FLGT Stock Holding History

Corebridge Financial’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,091
Closed -$171K – 1002
2025
Q1 		$171K Sell
10,091
-862
-8% -$14.7K ﹤0.01% 2163
2024
Q4 		$202K Sell
10,953
-703
-6% -$13.7K ﹤0.01% 2178
2024
Q3 		$253K Sell
11,656
-137
-1% -$3.06K ﹤0.01% 2088
2024
Q2 		$231K Buy
+11,793
New +$246K ﹤0.01% 2101

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Corebridge Financial's FLGT Position: Q2 2025 in Review

Corebridge Financial sold out of Fulgent Genetics (FLGT) in Q2 2025, closing a stake of 10,091 shares — an estimated $171K sold.

Corebridge Financial first reported a position in FLGT in Q2 2024 and held it in 4 quarters. The position peaked at $253K in Q3 2024. 167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

  • Corebridge Financial reported no remaining Fulgent Genetics position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 10,091 Fulgent Genetics shares in Q2 2025, an estimated $171K.
  • Corebridge Financial first reported a position in Fulgent Genetics in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Fulgent Genetics position peaked at $253K in Q3 2024.
  • 167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.